Skip to main content

Advertisement

Log in

The NEI VFQ-25 vision-related quality of life and prevalence of eye disease in a working population

  • Miscellaneous
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To apply the National Eye Institute 25-item Visual Function Questionnaire (VFQ-25) to a large group of working people and assess the prevalence of eye disease.

Methods

In this cross-sectional study, 619 employees of two large enterprises in Munich, Germany, underwent complete ophthalmological examination and assessment of the vision-related quality of life by the Visual Function Questionnaire (VFQ-25, German translation). Statistical analysis including binary logistic regression to investigate predictive factors of eye disease was performed.

Results

The age of the participants was mean 42 years. In 108 patients (17.4%) an ophthalmological disease was present. The mean VFQ-25 composite score was 91.1, and was not significantly different between the group with (88.8) or without (91.6) eye disease. A clear age dependency of VFQ-25 scores was seen. Most reduced subscales in eye disease were ocular pain and role difficulties. Patients with amblyopia did not show any reduction in visual quality of life (composite score 93.4). In the binary regression model, considering the clinical parameters intraocular pressure (IOP), cup/disc ratio (CDR), and spherical equivalent, as well as some of the VFQ-25 subscales, the presence of eye disease could be predicted with a high specificity of 98.7% but a low sensitivity of 12.2%.

Conclusions

Normal values of the VFQ-25 performance in a large number of working people in Germany are given with a clear age dependency. A combination of refraction, IOP, CDR and some VFQ subscales could reasonably well exclude any prevalent eye disease. For screening purposes, neither variable nor combination was sufficiently sensitive and specific.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Hirneiss C, Neubauer AS, Welge-Lussen U, Eibl K, Kampik A (2003) Measuring patient's quality of life in ophthalmology. Ophthalmologe 100:1091–1097

    Article  CAS  PubMed  Google Scholar 

  2. Mangione CM, Berry S, Spritzer K, Janz NK, Klein R, Owsley C, Lee PP (1998) Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol 116:227–233

    CAS  PubMed  Google Scholar 

  3. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD (2001) Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 119:1050–1058

    CAS  PubMed  Google Scholar 

  4. Hirneiss C, Neubauer AS, Gass CA, Reiniger IW, Priglinger SG, Kampik A, Haritoglou C (2007) Visual quality of life after macular hole surgery: outcome and predictive factors. Br J Ophthalmol 91:481–484

    Article  PubMed  Google Scholar 

  5. Franke GH, Esser J, Voigtländer A, Mähner N (1998) Der National Eye Institute Visual Function Questionnaire (NEI-VFQ)—Erste Ergebnisse zur psychometrischen Überprüfung eines Verfahrens zur Erfassung der Lebensqualität bei Sehbeeinträchtigten. Z Med Psychol 7:178–184

    Google Scholar 

  6. Wilson JMG JG: Principles and practice of screening for disease. Available from: http://www.who.int/bulletin/volumes/86/4/07-050112BP.pdf In Genova, WHO, 1968

  7. Pauleikhoff D, Scheider A, Wiedmann P, Gelisken F, Scholl HP, Roider I, Mohr A, Zlateva G, Xu X (2009) Neovascular age-related macular degeneration in Germany. Encroachment on the quality of life and the financial implications. Ophthalmologe 106:242–251

    Article  CAS  PubMed  Google Scholar 

  8. Schnell R, Hill PB, Esser E (1999) Methoden der empirischen Sozialforschung ed 6. Auflage, München, Oldenburg

    Google Scholar 

  9. Klein R, Moss SE, Klein BE, Gutierrez P, Mangione CM (2001) The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol 119:733–740

    CAS  PubMed  Google Scholar 

  10. Varma R, Wu J, Chong K, Azen SP, Hays RD (2006) Impact of severity and bilaterality of visual impairment on health-related quality of life. Ophthalmology 113:1846–1853

    Article  PubMed  Google Scholar 

  11. Chang TS, Bressler NM, Fine JT, Dolan CM, Ward J, Klesert TR (2007) Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 125:1460–1469

    Article  CAS  PubMed  Google Scholar 

  12. McKean-Cowdin R, Wang Y, Wu J, Azen SP, Varma R, Los Angeles Latino Eye Study Group (2007) Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study. Ophthalmology 115:941–948

    Article  PubMed  Google Scholar 

  13. Deramo VA, Cox TA, Syed AB, Lee PP, Fekrat S (2003) Vision-related quality of life in people with central retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 121:1297–1302

    Article  PubMed  Google Scholar 

  14. Schiffman RM, Walt JG, Jacobsen G, Doyle JJ, Lebovics G, Sumner W (2003) Utility assessment among patients with dry eye disease. Ophthalmology 110:1412–1419

    Article  PubMed  Google Scholar 

  15. Muir KW, Santiago-Turla C, Stinnett SS, Herndon LW, Allingham R, Challa P, Lee PP (2008) Health literacy and vision-related quality of life. Br J Ophthalmol 92:779–782

    Article  CAS  PubMed  Google Scholar 

  16. Globe D, Varma R, Azen SP, Paz S, Yu E, Preston-Martin S (2003) Psychometric performance of the NEI VFQ-25 in visually normal Latinos: the Los Angeles Latino Eye Study. Invest Ophthalmol Vis Sci 44:1470–1478

    Article  PubMed  Google Scholar 

  17. McKean-Cowdin R, Varma R, Wu J, Hays RD, Azen SP (2007) Severity of visual field loss and health-related quality of life. Am J Ophthalmol 143:1013–1023

    Article  PubMed  Google Scholar 

  18. Williams C, Northstone KM, Howard M, Harvey I, Harrad R, Sparrow J (2008) Prevalence and risk factors for common vision problems in children: data from the ALSPAC study. Br J Ophthalmol 92:959–964

    Article  CAS  PubMed  Google Scholar 

  19. Drover JR, Kean PG, Courage ML, Adams RJ (2008) Prevalence of amblyopia and other vision disorders in young Newfoundland and Labrador children. Can J Ophthalmol 43:89–94

    Article  PubMed  Google Scholar 

  20. Carlton J, Karnon J, Czoski-Murray C, Smith KJ, Marr J (2008) The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4–5 years: a systematic review and economic evaluation. Health Technol Assess 12:1–214

    Google Scholar 

  21. Uchino M, Schaumberg DA, Dogru M, Uchino Y, Fukagawa K, Shimmura S, Satoh T, Takebayashi T, Tsubota K (2008) Prevalence of dry eye disease among Japanese visual display terminal users. Ophthalmology 115:1982–1988

    Article  PubMed  Google Scholar 

  22. O’Connor P, Keeffe J, Pesudovs K, Marella M, Lamoureux E (2009) Comparing the Psychometric Performance of the Impact of Vision Impairment (IVI) and the National Eye Institute Visual Functioning Questionnaire-25 (NEI VFQ-25). In ARVO 2009 Annual Meeting. Fort Lauderdale, Florida

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christoph Hirneiß.

Additional information

The authors do not have any commercial interest in any of the materials and methods used in this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hirneiß, C., Schmid-Tannwald, C., Kernt, M. et al. The NEI VFQ-25 vision-related quality of life and prevalence of eye disease in a working population. Graefes Arch Clin Exp Ophthalmol 248, 85–92 (2010). https://doi.org/10.1007/s00417-009-1186-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-009-1186-3

Keywords

Navigation